MEDICAL ENGINEERING & PHYSICS, published by Elsevier Science Ltd, is an esteemed journal in the fields of Biomedical Engineering and Biophysics. With an ISSN of 1350-4533 and an E-ISSN of 1873-4030, it has established itself as a significant resource from its inception in 1994, continuing to deliver pivotal research up to 2024. This journal, categorized in the Q3 quartile for both Biomedical Engineering and Biophysics, holds a respectable position in Scopus rankings, boasting its relevance in the upper echelons of academic inquiry, particularly ranking #75/152 in Biophysics and #158/303 in Biomedical Engineering. Authors and researchers in these dynamic fields will find the journal’s rigorous peer-review process and commitment to publishing high-quality original research invaluable for advancing their work. Although the journal is not open access, it continues to attract submissions that push the boundaries of innovation and application in medical technologies, making it an essential resource for anyone dedicated to the integration of engineering principles with medical sciences.

IRBM, published by Elsevier Science Inc, stands at the forefront of research in the domains of Biomedical Engineering and Biophysics, boasting impressively high rankings with a Q1 category in both fields according to the 2023 evaluations. With an effective focus on cutting-edge innovations and methodologies, IRBM provides a vital platform for researchers, professionals, and students alike seeking to disseminate and access groundbreaking findings and developments. Its strong presence in the Scopus database, with ranks of #12 in Biochemistry, Genetics and Molecular Biology and #42 in Biomedical Engineering, places it in the top percentile of impactful journals in the field, making it a crucial resource for advancing knowledge and fostering collaboration. While the journal maintains a traditional subscription model, it continues to attract a diverse readership eager for insightful studies and reviews that push the boundaries of science and engineering. With a projected convergence of years extending to 2024, IRBM promises to remain a significant contributor to the ongoing dialogue in the life sciences.

The Journal of Biomimetics Biomaterials and Biomedical Engineering, published by TRANS TECH PUBLICATIONS LTD, stands at the forefront of interdisciplinary research that merges biology with engineering to address real-world challenges in healthcare and material science. Since its inception in 2014, the journal has contributed valuable insights into the development of innovative biomaterials and biomedical applications, showcasing research excellence in its fields, including biotechnology and bioengineering. With an ISSN of 2296-9837 and an E-ISSN of 2296-9845, this journal provides a platform for both emerging and established researchers to disseminate their work, fostering knowledge transfer across the global scientific community. Currently positioned in the Q4 quartile across categories such as Bioengineering, Biomedical Engineering, and Biotechnology, it aims to enhance its impact through open-access policies and rigorous peer-review processes. With its headquarters in Germany, the journal welcomes diverse contributions from around the world, shaping the future of biomimetic technologies and advancing our understanding of complex biomedical systems.

The Journal of Mechanics in Medicine and Biology, published by World Scientific Publishing Co Pte Ltd, serves as a critical platform for interdisciplinary research at the intersection of engineering and biomedical sciences. With an ISSN of 0219-5194 and E-ISSN of 1793-6810, this esteemed journal has been dedicated to exploring the mechanical principles that govern biological systems since its inception in 2008. Based in Singapore, it addresses a diverse range of topics, from biomaterials to biomechanics, contributing valuable insights into the field’s evolving landscape. Although currently positioned in Q4 of Biomedical Engineering according to the 2023 category quartiles, it is poised for growth and increased visibility within the scientific community, fostering innovation and collaboration among researchers, professionals, and students alike. The journal emphasizes the importance of cutting-edge research and its practical implications, making it a vital resource for those striving to enhance the future of medical technologies and biological understanding.

Biomedical Engineering-Biomedizinische Technik, published by WALTER DE GRUYTER GMBH, serves as a pivotal platform for advancing knowledge in the field of biomedical engineering and medicine since its inception in 1956. With an ISSN of 0013-5585 and an E-ISSN of 1862-278X, this peer-reviewed journal offers accessible insights into innovative research and technological advancements that are reshaping healthcare practices and biomedical applications. Although rated in the Q3 category for both Biomedical Engineering and Miscellaneous Medicine in 2023, the journal's impact factor and growing reputation demonstrate its vital role in fostering academic dialogue and collaboration. The journal is based in Germany, while its scope encompasses a diverse range of topics, thus bridging the gap between engineering and medical disciplines. Researchers, professionals, and students alike are encouraged to engage with the content that not only highlights contemporary challenges but also presents groundbreaking solutions in biomedical technology.

Cardiovascular Engineering and Technology, published by SPRINGER, stands as a prominent journal in the fields of Biomedical Engineering and Cardiology. With an ISSN of 1869-408X, this journal bridges the gap between engineering innovation and cardiovascular health by exploring the latest advancements pertinent to cardiovascular technologies and therapies. The journal, currently in its converged years from 2010 to 2024, holds important positions in Quartile 3 of both Biomedical Engineering and Cardiology and Cardiovascular Medicine categories, highlighting its relevance and influence in these domains. Ranked in the 59th percentile for Cardiology and 42nd percentile for Biomedical Engineering, the journal is a valuable resource for researchers, professionals, and students keen on understanding the intersection of engineering solutions and cardiovascular medicine. Although the journal is not open access, it remains highly regarded for its rigorous peer-reviewed content that contributes to the advancement of technology in the cardiovascular field.

Journal of Medical Signals & Sensors, published by Wolters Kluwer Medknow Publications, is a pioneering platform in the fields of Biomedical Engineering, Computer Science, and Health Informatics, focusing on innovative research and advancements in medical technology. With an Open Access policy since 2012, the journal promotes widespread dissemination of knowledge, aiming to facilitate the sharing of vital insights and developments among researchers, healthcare professionals, and students globally. The journal has achieved commendable rankings in its various categories, including Q3 in Biomedical Engineering and Radiology, underscoring its importance in advancing health technology and informatics. Its commitment to rigorous peer review ensures that published works are of the highest quality, making it a valuable resource for those engaged in cutting-edge medical research. With annual publications planned through 2024, the Journal of Medical Signals & Sensors continues to expand its influence and relevance in a rapidly evolving scientific landscape.

Advanced NanoBiomed Research is a pioneering open-access journal committed to advancing the interdisciplinary field of nanobiotechnology, published by WILEY-V C H VERLAG GMBH. Since its inception in 2021, this journal has provided a platform for innovative research that bridges the gap between engineering, medicine, and materials science. With impressive rankings in Scopus, positioning it within the top quartiles of various categories, Advanced NanoBiomed Research aims to disseminate high-quality research that contributes to the understanding and application of nanomaterials in biomedical contexts. As it encompasses a wide scope—from applied microbiology to biomaterials—it serves as an essential resource for researchers, professionals, and students eager to explore the cutting-edge developments in the field. The journal promotes a collaborative environment where emerging ideas can flourish, ensuring that vital advancements in nanobiomedicine can be shared and built upon within the scientific community.

Biocybernetics and Biomedical Engineering, published by ELSEVIER in the Netherlands, is a prestigious journal that stands at the forefront of the intersecting fields of biomedical engineering and artificial intelligence. With an impressive Impact Factor that places it in the Q1 category for Biomedical Engineering, this journal not only ranks 17th out of 303 in Scopus but also boasts a remarkable percentile ranking of 94th, highlighting its influence and relevance within the scientific community. Since its inception in 2008, Biocybernetics and Biomedical Engineering has aimed to publish cutting-edge research that integrates principles of cybernetics with technological advancements in health care, thereby fostering innovations that improve patient outcomes. Dedicated to advancing knowledge in biomedical technology, the journal serves as a vital resource for researchers, professionals, and students seeking to explore the latest developments and methodologies in the field.

AIMS Bioengineering, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed open-access journal dedicated to advancing knowledge in the interdisciplinary field of bioengineering. With the ISSN 2375-1495, this journal has been providing a platform for the rapid dissemination of high-quality research since its establishment in 2014. AIMS Bioengineering covers a wide range of topics, including but not limited to, biomaterials, computational biology, and bioinformatics, making it an essential resource for researchers, professionals, and students alike. Although the H-index and specific category quartiles are not currently available, the journal's commitment to open access ensures that cutting-edge findings are accessible to a global audience, fostering collaboration and innovation in bioengineering. With its rigorous peer-review process and dedication to scholarly excellence, AIMS Bioengineering continues to play a pivotal role in shaping the future of the bioengineering landscape.